Asclepii
PrivateLast Round
Grant
Apr 8, 2025
Total Funding Raised
$2.52M
Company Overview
Asclepii operates in Healthcare & Life Sciences and is based in Cleveland, Ohio. Its latest recorded funding round was a Grant round in April 2025.
Asclepii is a biotechnology company that develops regenerative medicine and advanced wound care solutions, including its flagship nanosilver hydrogel product, Poseidon.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Asclepii Comparables
Compare Asclepii with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Organogenesis Holdings Inc. | 75% | |
| ConvaTec Group PLC | 74% | |
| ParaNano Wound Care | 74% |
For institutional investors. Book with your work email.
Asclepii Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 8, 2025 | ||||
| Seed | Mar 21, 2025 | ||||
| Grant | Apr 26, 2024 | ||||
| Accelerator | Apr 17, 2024 | ||||
| Grant | Mar 8, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Asclepii Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Venturance | Seed |
| Zentynel Frontier Investments | Seed |
| JumpStart | Accelerator |
| Capital Factory | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 22, 2026
Monthly visitors grew 42% MoM.
- Jun 1, 2025
Monthly visitors increased 468% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventSep 4, 2026
Asclepii is selected to exhibit Poseidon Nanosilver Hydrogel at Vizient Innovative Technology Exchange in Nevada on Sep 24th '26.
For institutional investors. Book with your work email.
Asclepii Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Asclepii's valuation, stock price, and market status.
Is Asclepii a public or private company?
Asclepii is a private company.
What is the current stock price of Asclepii?
Asclepii is a private company, so its shares have no public market price. Caplight tracks Asclepii's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Asclepii worth (valuation)?
Valuation information for Asclepii is not publicly available.
Can I buy Asclepii stock?
Asclepii shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Asclepii's last funding round?
Asclepii's most recent funding round was Grant on April 8, 2025.
Who are the main investors in Asclepii?
Key investors in Asclepii include Zentynel Frontier Investments.
Will Asclepii IPO soon?
No public IPO plans have been announced for Asclepii.
How can I track Asclepii secondary market activity?
Caplight tracks bids, offers, and trades in Asclepii's shares on secondary markets.